Hims & Hers Health (HIMS) Retained Earnings (2019 - 2026)
Hims & Hers Health (HIMS) reported Retained Earnings of -$205.9 million for Q1 2026, down 125440.85% on a YoY basis from N/an in Q1 2025, and down 80.96% sequentially from -$113.8 million in Q4 2025.
Hims & Hers Health (HIMS) Retained Earnings (2019 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 8 years of Retained Earnings data on file, last reported at -$205.9 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 125440.85% year-over-year to -$205.9 million; the trailing twelve-month figure through Mar 2026 stood at -$205.9 million (down 125440.85% YoY), and the FY2025 full-year result was -$113.8 million, down 35014.81% from the prior year.
- Retained Earnings slipped to -$205.9 million in Q1 2026, from -$113.8 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $229000.0 in Q3 2024 to a low of -$368.2 million in Q4 2023.
- A 5-year average of -$156.8 million and a median of -$134.4 million in 2025 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 272.18% in 2024, while the deepest fall reached 133136.43% in 2024.
- Tracing HIMS's Retained Earnings over 5 years: stood at -$344.6 million in 2022, then fell by 6.83% to -$368.2 million in 2023, then soared by 99.91% to -$324000.0 in 2024, then plunged by 35014.81% to -$113.8 million in 2025, then slumped by 80.96% to -$205.9 million in 2026.
- Business Quant data shows HIMS's Retained Earnings at -$205.9 million in Q1 2026, -$113.8 million in Q4 2025, and -$134.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 8.83 Bn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | -413.76 Mn |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | -205.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -205.89 Mn |
| Dec 31, 2025 | -113.77 Mn |
| Sep 30, 2025 | -134.37 Mn |
| Jun 30, 2025 | -150.15 Mn |
| Mar 31, 2025 | -164,000.00 |
| Dec 31, 2024 | -324,000.00 |
| Sep 30, 2024 | 229,000.00 |
| Jun 30, 2024 | -343.75 Mn |
| Mar 31, 2024 | -162,000.00 |
| Dec 31, 2023 | -368.18 Mn |
| Sep 30, 2023 | -133,000.00 |
| Jun 30, 2023 | -258,000.00 |
| Mar 31, 2023 | -354.70 Mn |
| Dec 31, 2022 | -344.63 Mn |
| Sep 30, 2022 | -333.72 Mn |
| Jun 30, 2022 | -314.88 Mn |
| Mar 31, 2022 | -323,000.00 |
| Dec 31, 2021 | -278.95 Mn |
| Sep 30, 2021 | -247.79 Mn |
| Jun 30, 2021 | -231.85 Mn |